Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells.
about
Brain tumor stem cells: Molecular characteristics and their impact on therapyRegulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent.Different involvement of promoter methylation in the expression of organic cation/carnitine transporter 2 (OCTN2) in cancer cell linesAA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of TumorsMelatonin for the prevention and treatment of cancerDoxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signalGenome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.Stem cells and gliomas: past, present, and future.Future perspectives for mTOR inhibitors in renal cell cancer treatment.Melatonergic system-based two-gene index is prognostic in human gliomas.ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer.Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM.Renal Drug Transporters and Drug Interactions.Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers.Pregnancy promotes pituitary tumors by increasing the rate of the cell cycle.Melatonin-induced increase of lipid droplets accumulation and in vitro maturation in porcine oocytes is mediated by mitochondrial quiescence.Involvement of autophagy in melatonin-induced cytotoxicity in glioma-initiating cells.Obstacles to Brain Tumor Therapy: Key ABC Transporters.Melatonin impedes Tet1-dependent mGluR5 promoter demethylation to relieve pain.Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis.
P2860
Q27003138-ADB20800-C818-442D-8D5E-F72107CB45C3Q27330365-C8A512E9-259A-4291-8B12-AFE96C0DA1AAQ28534471-27FD6B48-9F1C-4FE2-8BAC-2C6554BCB446Q33838881-49AF6B13-957B-49E1-B51F-F968E7A96E3FQ33889427-70DA7ECB-739B-4193-9C8E-66C02FA2839FQ35815736-4D50FA49-29D3-4978-9618-B3321ED1DD14Q36213162-7F703C5B-990E-4537-9356-5D5F92D153FFQ36795940-07340CBC-FD28-42C4-A001-CDEE3604FDD9Q38235856-7E1492B9-0974-464E-9F37-EC8D6874F8D1Q38372445-D30C9BC2-F41B-4294-85EA-23BF99E115B8Q38824160-8937353B-C341-4276-B542-2108FCCBAECAQ38848383-C2D8491F-21B0-4723-9223-D08777EAADC2Q38885201-0760D2AF-FD4A-4C38-9C20-8C6876C61B46Q39090430-F9FEF6C9-82BF-45DD-808E-A724DEF6A9FBQ39140289-86FB7D18-5362-4AA7-A8DD-EB8DFB6E766CQ41103172-67E78A6E-000A-4959-82AE-74E03F325BABQ45733182-9EEAC2F8-282A-4123-A221-CC1CA2BD5DBDQ46412121-E4969156-0597-4DE0-A2EF-4D63B36CB872Q46986339-A9E44434-2E46-43F1-81FE-49666B349F39Q47944360-9898D86F-E55C-417B-941F-6F3BAA64E22CQ48108816-4B37C415-153E-478B-848D-A47788D0DAB2Q53113443-2B3F7B15-562A-4FE7-858E-C0AE41E618A4
P2860
Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Melatonin-induced methylation ...... ce in brain tumour stem cells.
@en
Melatonin-induced methylation ...... ce in brain tumour stem cells.
@nl
type
label
Melatonin-induced methylation ...... ce in brain tumour stem cells.
@en
Melatonin-induced methylation ...... ce in brain tumour stem cells.
@nl
prefLabel
Melatonin-induced methylation ...... ce in brain tumour stem cells.
@en
Melatonin-induced methylation ...... ce in brain tumour stem cells.
@nl
P2093
P2860
P356
P1476
Melatonin-induced methylation ...... nce in brain tumour stem cells
@en
P2093
C Gomez-Manzano
C Rodriguez
M A Alvarez-Vega
P2860
P2888
P304
P356
10.1038/BJC.2013.188
P407
P577
2013-04-30T00:00:00Z